Efficacy of propafenone in paramyotonia congenita

被引：19

作者：

Alfonsi, E.

Merlo, I. M.

Tonini, M.

Ravaglia, S.

Brugnoni, R.

Gozzini, A.

Moglia, A.

机构：

[1] Univ Pavia, Fdn Ist Neurol C Mondino, IRCCS, Clin Neurophysiol Unit, I-27100 Pavia, Italy

[2] Univ Pavia, Dept Physiol & Pharmacol Sci, I-27100 Pavia, Italy

[3] IRCCS, Fdn Ist Neurol C Besta, Dept Neuromuscular Dis, NBS Biotech scrl, Milan, Italy

来源：

NEUROLOGY | 2007年 / 68卷 / 13期

关键词：

D O I：

10.1212/01.wnl.0000257825.29703.e8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：1080 / 1081

页数：2

共 7 条

[1]

CANNON SC, 2003, NEUROLOGICAL THERAPE, P2365

[2] PROPAFENONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN THE TREATMENT OF ARRHYTHMIAS [J].

HARRON, WG ;

BROGDEN, RN .

DRUGS, 1987, 34 (06) :617-647

[3] MYOTONIC-DYSTROPHY - CLINICAL-ASSESSMENT OF MUSCULAR DISABILITY IN AN ISOLATED POPULATION WITH PRESUMED HOMOGENEOUS MUTATION [J].

MATHIEU, J ;

DEBRAEKELEER, M ;

PREVOST, C ;

BOILY, C .

NEUROLOGY, 1992, 42 (01) :203-208

[4]

PTACEK LJ, 1992, NEURON, V8, P891

[5] TRANSIENT PARESIS IN MYOTONIC SYNDROMES - A SIMPLIFIED ELECTROPHYSIOLOGIC APPROACH [J].

STREIB, EW ;

SUN, SF ;

YARKOWSKY, T .

MUSCLE & NERVE, 1982, 5 (09) :719-723

[6] Human skeletal muscle sodium channelopathies [J].

Vicart, S ;

Sternberg, D ;

Fontaine, B ;

Meola, G .

NEUROLOGICAL SCIENCES, 2005, 26 (04) :194-202

[7] Inactivation-deficient human skeletal muscle Na+ channels (hNav1.4-L443C/A444W) in stably transfected HEK-293 cells [J].

Wang, SY ;

Moczydlowski, E ;

Wang, GK .

RECEPTORS & CHANNELS, 2004, 10 (3-4) :131-138

← 1 →